Antibody and inhibitor, and transfection method or kit using them
CA 2489316 A1 · Owner: Matsumoto, Misako · Inventors: Matsumoto, Misako; Seya, Tsukasa
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is intended to provide a monoclonal antibody binding specifically to human Toll-like receptor 3. Also, use is made of an inhibitor inhibiting the production of type I interferon by cells expressing a Toll-like receptor recognizing a double-stranded RNA and producing type I interferon which , contains an antibody binding to a Toll-like receptor in particular, a , monoclonal antibody against human Toll-like receptor 3. In the state of inhibiting the production of type I interferon with the use of the above inhibitor, the cells are infected with a recombinant RNA virus vector having a target gene inserted thereinto and thus transformed. By inhibiting the production of type I …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 17, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 17, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 17, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.